Strand Life Sciences secures Indian patent for early cancer detection platform using cfDNA analysis from a single blood ...
A machine learning program that identified patients overdue for colorectal cancer screening helped increase screening rates ...
Colorectal cancer is associated with certain microbiomes that produce microbial signatures that can be detected by a ...
1don MSN
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its ...
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence and canine biology. That’s the thesis behind SpotitEarly, a startup that recently launched in the ...
Caris Life Sciences ® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection technology ...
Patented platform uses cell-free DNA analysis and machine learning to detect cancer early and identify tissue of origin from ...
Reliance’s Strand Life Sciences patents a blood-based technology for early cancer detection, enhancing accuracy and accessibility.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results